Product Name: Human TLR2 Antibody (Tomaralimab, Research Use)
Catalog Number: NBR-0293
Target Name: TLR2
Trade Name: Tomaralimab
Antibody Drug Description: Tomaralimab (OPN305) is a first-in-class humanised monoclonal antibody against Toll-like receptor 2 (TLR2) being developed by Opsona Therapeutics. It is being investigated for potential clinical use in certain hematological and immunological conditions. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: TLR2
Synonyms: CD282; TIL4
Target Description: Cooperates with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. Cooperates with TLR1 or TLR6 to mediate the innate immune response to bacterial lipoproteins or lipopeptides.
Ensembl: ENSG00000137462 
Uniprot: O60603